Literature DB >> 6806451

Synthesis and biological evaluation of Tc-99m N,N'-bis(mercaptoacetyl)-2,3-diaminopropanoate: a potential replacement for [131I]o-iodohippurate.

A R Fritzberg, C C Kuni, W C Klingensmith, J Stevens, W P Whitney.   

Abstract

A new technetium-chelating agent based on amide and mercaptide donor groups, N,N'-bis(mercaptoacetyl)-2,3-diaminopropanoate, was synthesized as an analog of previously described N,N'-bis(mercaptoacetyl)ethylenediamine (DADS). Complexation of Tc-99m with the new chelating group resulted in two components that were separable by high-performance liquid chromatography. The component that eluted first demonstrated high specificity for renal excretion, with over 90% in the urine of rabbits at 35 min, 87% in the urine of mice at 2 hr, and 1.6% or less in the intestines of mice. Excretion was rapid, with the first component equaling or exceeding [131I]o-iodohippurate in the urine of rabbits at all times. The second or latter component demonstrated comparable specificity but slightly slower renal excretion kinetics. Clinical trials with the first component are probably warranted.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6806451

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  11 in total

1.  Dynamic renal scanning using 99mTc-MAG-3 in man.

Authors:  C L Maini; P Antonacci; A Sargiotto; G Castellano; V Podio
Journal:  Eur J Nucl Med       Date:  1989

2.  (99m)Tc(CO)3(NTA): a (99m)Tc renal tracer with pharmacokinetic properties comparable to those of (131)I-OIH in healthy volunteers.

Authors:  Andrew T Taylor; Malgorzata Lipowska; Luigi G Marzilli
Journal:  J Nucl Med       Date:  2010-02-11       Impact factor: 10.057

3.  First evaluation of a 99mTc-tricarbonyl complex, 99mTc(CO)3(LAN), as a new renal radiopharmaceutical in humans.

Authors:  Malgorzata Lipowska; Haiyang He; Eugene Malveaux; Xiaolong Xu; Luigi G Marzilli; Andrew Taylor
Journal:  J Nucl Med       Date:  2006-06       Impact factor: 10.057

4.  Structural and Spectral Analyses of 2-[(2-Benzothiazolylmethyl)thio]-benzenamine and 2-[(2-Benzothiazolylmethyl)thio]-benzenamine hydrobromide.

Authors:  Dustin W Demoin; Charles L Barnes; Timothy J Hoffman; Silvia S Jurisson
Journal:  J Chem Crystallogr       Date:  2011-02-04       Impact factor: 0.603

5.  Initial Evaluation of (99m)Tc(CO)3(ASMA) as a Renal Tracer in Healthy Human Volunteers.

Authors:  Malgorzata Lipowska; Jeffrey Klenc; Russell D Folks; Andrew T Taylor
Journal:  Nucl Med Mol Imaging       Date:  2014-05-27

6.  Evaluation of the renal excretion characteristics of technetium-99m mercaptoacetylglycyl-D-alanylglycine in healthy volunteers.

Authors:  G M Bormans; B J Cleynhen; M J De Roo; A M Verbruggen
Journal:  Eur J Nucl Med       Date:  1992

7.  N-Succinyldesferrioxamine B: a potential radiopharmaceutical for assessing renal function.

Authors:  J D Herscheid; A Hoekstra; C M Vos
Journal:  Eur J Nucl Med       Date:  1984

8.  99mTc-MAG3, a new renal imaging agent: preliminary results in patients.

Authors:  A Taylor; D Eshima; N Alazraki
Journal:  Eur J Nucl Med       Date:  1987

9.  Clinical experience with 99mTc-MAG3, mercaptoacetyltriglycine, and a comparison with 99mTc-DTPA.

Authors:  A A Al-Nahhas; R A Jafri; K E Britton; K Solanki; J Bomanji; S Mather; M A Carroll; M Al-Janabi; V Frusciante; B Ajdinowic
Journal:  Eur J Nucl Med       Date:  1988

10.  Technetium thiodiglycollic acid (99mTc-TDG). A new radiopharmaceutical with the potential for the assessment of renal function.

Authors:  D P Nowotnik; R D Pickett; C D Allen
Journal:  Eur J Nucl Med       Date:  1985
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.